Keystone Clinical Studies LLC entered the industry of Medical Research in 2003 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code , which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Tom Verghese by calling (610) 277-8073 during business hours. You can also write to the business’ Branch at 2460 General Armistead Ave
Suite 300, Norristown, Pennsylvania PA 19403. You can also visit the company’s website at keystoneclinicalstudies.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Keystone Clinical Studies LLC |
| Representative: | Tom Verghese |
| Place of Business: | 2460 General Armistead Ave Suite 300, Norristown, PA 19403 |
| Contact Number: | (610) 277-8073 |
| Website: | keystoneclinicalstudies.com |
| Type of Service: | Medical Research |
| Locality: | Branch |
| Market Type: | B2B (Business to Business) |
| Began: | 2003 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Keystone Clinical Studies LLC is a company operating from Montgomery, Pennsylvania providing professional Medical Research and relevant B2B variables. It was founded in 2003 and registered with the SIC code as Medical Research, and with the NAICS code as Medical Research.
With a current employee count of 1 to 4, Keystone Clinical Studies LLC has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Tom Verghese at (610) 277-8073 for related queries, or to locate its Branch using the coordinates 40.1244,-75.39992.
The Branch can also be found at the street address 2460 General Armistead Ave
Suite 300 in Norristown, Pennsylvania 19403 and can be engaged online through the company website at keystoneclinicalstudies.com, the company Twitter , and Facebook page .